BR112015011798A2 - métodos e composições para tratar doenças neurodegenerativas - Google Patents

métodos e composições para tratar doenças neurodegenerativas

Info

Publication number
BR112015011798A2
BR112015011798A2 BR112015011798A BR112015011798A BR112015011798A2 BR 112015011798 A2 BR112015011798 A2 BR 112015011798A2 BR 112015011798 A BR112015011798 A BR 112015011798A BR 112015011798 A BR112015011798 A BR 112015011798A BR 112015011798 A2 BR112015011798 A2 BR 112015011798A2
Authority
BR
Brazil
Prior art keywords
compositions
methods
neurodegenerative diseases
treating neurodegenerative
treating
Prior art date
Application number
BR112015011798A
Other languages
English (en)
Inventor
Chen Chih-Ming
Liu Sheng-Yung
Wen Wu-Che
Original Assignee
Golden Biotechnology Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Golden Biotechnology Corp filed Critical Golden Biotechnology Corp
Publication of BR112015011798A2 publication Critical patent/BR112015011798A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

resumo “métodos e composições para tratar doenças neurodegenerativas” a presente invenção refere-se a métodos e composições para tratar doenças neurodegenerativas por compostos de ciclo-hexanona.
BR112015011798A 2012-11-21 2013-11-18 métodos e composições para tratar doenças neurodegenerativas BR112015011798A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261729295P 2012-11-21 2012-11-21
PCT/US2013/070625 WO2014081675A1 (en) 2012-11-21 2013-11-18 Methods and compositions for treating neurodegenerative diseases

Publications (1)

Publication Number Publication Date
BR112015011798A2 true BR112015011798A2 (pt) 2017-07-11

Family

ID=50728525

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015011798A BR112015011798A2 (pt) 2012-11-21 2013-11-18 métodos e composições para tratar doenças neurodegenerativas

Country Status (14)

Country Link
US (1) US9861592B2 (pt)
EP (1) EP2922534B1 (pt)
JP (1) JP6407876B2 (pt)
KR (1) KR102088078B1 (pt)
CN (1) CN104968339B (pt)
AU (1) AU2013348248B2 (pt)
BR (1) BR112015011798A2 (pt)
CA (1) CA2892084C (pt)
ES (1) ES2788598T3 (pt)
HK (1) HK1215548A1 (pt)
MX (1) MX2015006337A (pt)
TW (1) TWI559917B (pt)
WO (1) WO2014081675A1 (pt)
ZA (1) ZA201504292B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201632491A (zh) * 2014-09-09 2016-09-16 翁慶豐 安卓奎諾爾於治療肥胖的用途及製備安卓奎諾爾的方法
CN107847473B (zh) * 2015-05-29 2021-08-10 香港大学 新型神经保护性和神经修复性n-炔丙基咖啡酰胺(paca)及作为神经变性疾病的疗法的用途
TW201733573A (zh) * 2016-03-25 2017-10-01 Ying-Yu Guo 牛樟芝化合物用於製備治療及預防神經退行性疾病之藥物的用途
CN107296805A (zh) * 2016-04-14 2017-10-27 郭盈妤 牛樟芝化合物及其萃取物用于制备治疗及预防神经退行性疾病的药物的用途
WO2019160150A1 (ja) * 2018-02-19 2019-08-22 國子 草間 バレロラクトン（Ｖａｌｅｒｏｌａｃｔｏｎｅ）系新規化合物、及び、医薬
TW202038981A (zh) * 2018-11-28 2020-11-01 薩摩亞商吉亞生技控股股份有限公司 治療失智症的組合物及方法
CN110200998B (zh) * 2019-05-24 2021-04-16 清华大学 神经元来源外泌体的制备及其在治疗老年痴呆症中的应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993073A (en) 1969-04-01 1976-11-23 Alza Corporation Novel drug delivery device
US3598122A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4069307A (en) 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US3731683A (en) 1971-06-04 1973-05-08 Alza Corp Bandage for the controlled metering of topical drugs to the skin
US3996934A (en) 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
BE795384A (fr) 1972-02-14 1973-08-13 Ici Ltd Pansements
US3921636A (en) 1973-01-15 1975-11-25 Alza Corp Novel drug delivery device
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US3972995A (en) 1975-04-14 1976-08-03 American Home Products Corporation Dosage form
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4031894A (en) 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
US4031893A (en) 1976-05-14 1977-06-28 Survival Technology, Inc. Hypodermic injection device having means for varying the medicament capacity thereof
US4060084A (en) 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4201211A (en) 1977-07-12 1980-05-06 Alza Corporation Therapeutic system for administering clonidine transdermally
JPS5562012A (en) 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
US4230105A (en) 1978-11-13 1980-10-28 Merck & Co., Inc. Transdermal delivery of drugs
US4291015A (en) 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4476116A (en) 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
US5116817A (en) 1982-12-10 1992-05-26 Syntex (U.S.A.) Inc. LHRH preparations for intranasal administration
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
US5633009A (en) 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
US5695472A (en) 1993-05-27 1997-12-09 Washington Biotech Corporation Modular automatic or manual emergency medicine injection system
US5358489A (en) 1993-05-27 1994-10-25 Washington Biotech Corporation Reloadable automatic or manual emergency injection system
US5540664A (en) 1993-05-27 1996-07-30 Washington Biotech Corporation Reloadable automatic or manual emergency injection system
US5665378A (en) 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US6929801B2 (en) 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
US5869090A (en) 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US6946144B1 (en) 1998-07-08 2005-09-20 Oryxe Transdermal delivery system
JP4469441B2 (ja) 1999-02-10 2010-05-26 明治乳業株式会社 神経変性疾患の予防又は治療薬
US7544189B2 (en) 2000-10-10 2009-06-09 Meridian Medical Technologies, Inc. Needle and hub assembly for automatic injector
JP5150807B2 (ja) * 2005-02-28 2013-02-27 株式会社明治 ハイドロキノン長鎖誘導体及び／又はフェノキシ長鎖誘導体及びこれらを含有する医薬
TW200829234A (en) * 2007-01-08 2008-07-16 Golden Biotechnology Corp Antrodia camphorata isophorone extract
TWI394573B (zh) * 2007-06-14 2013-05-01 Golden Biotechnology Corp Application of Cynanchum auranthone Cyclohexenone Compounds in the Preparation of Drugs for Liver Protection
US8309611B2 (en) * 2010-09-20 2012-11-13 Golden Biotechnology Corporation Methods and compositions for treating lung cancer
FR2987264A1 (fr) * 2012-02-23 2013-08-30 Golden Biotechnology Corp Methodes et compositions pour le traitement des metastases cancereuses
WO2013148701A1 (en) * 2012-03-26 2013-10-03 Golden Biotechnology Corporation Methods and compositions for treating arteriosclerotic vascular diseases

Also Published As

Publication number Publication date
AU2013348248A1 (en) 2015-07-02
CA2892084C (en) 2020-11-10
TW201440758A (zh) 2014-11-01
US20140142194A1 (en) 2014-05-22
WO2014081675A1 (en) 2014-05-30
CN104968339A (zh) 2015-10-07
ES2788598T3 (es) 2020-10-22
TWI559917B (en) 2016-12-01
AU2013348248B2 (en) 2018-06-14
CN104968339B (zh) 2019-06-11
JP6407876B2 (ja) 2018-10-17
ZA201504292B (en) 2017-04-26
KR102088078B1 (ko) 2020-03-12
KR20150087844A (ko) 2015-07-30
EP2922534B1 (en) 2020-04-08
US9861592B2 (en) 2018-01-09
CA2892084A1 (en) 2014-05-30
HK1215548A1 (zh) 2016-09-02
EP2922534A1 (en) 2015-09-30
MX2015006337A (es) 2015-09-07
EP2922534A4 (en) 2016-05-11
JP2016500074A (ja) 2016-01-07

Similar Documents

Publication Publication Date Title
CY1122278T1 (el) Αντι il-36r αντισωματα
BR112015011798A2 (pt) métodos e composições para tratar doenças neurodegenerativas
UY33627A (es) Compuestos para tratar enfermedades neurodegenerativas
BR112016000903A2 (pt) anticorpos
CO7111287A2 (es) Composiciones plaguicidas y procesos relacionados
EA201890239A2 (ru) Фумараты как пролекарства и их применение при лечении различных заболеваний
BR112013020086A2 (pt) anticorpos que se ligam especificamente à alfa-toxina de staphylococcus aureus e métodos de utilização
CL2014000806A1 (es) Compuestos derivados de 1-arilcarbonil-4-oxi-piperidino; composicion farmaceutica que los comprende; uso para la prevencion o el tratamiento de enfermedades neurodegenerativas tales como enfermedad de alzheimer, enfermedad de parkinson, enfermedad de huntington o esclerosis multiple.
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
NZ710444A (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
BR112014009866A2 (pt) formulações de anticorpos e métodos
CO6741218A2 (es) Composición pesticida y procesos relacionados con el mismo
UY33906A (es) Composiciones herbicidas que comprenden topramezona
BR112013006567A2 (pt) métodos e composições para tratamento de câncer de pulmão
BR112015000329A2 (pt) formulações de diclofenac
BR112014025041B8 (pt) Composição farmacêutica
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
BR112018003526A2 (pt) métodos de tratamento de doenças inflamatórias
BR112014008555A2 (pt) r(+)-n-formil-propargil-aminoindano
BR112015019924A2 (pt) métodos e composições para tratar leucemia
WO2012104823A3 (en) Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
BR112017001221A2 (pt) derivados de indolizina que são aplicáveis a doenças neurodegenerativas
IN2015DN01524A (pt)
BR112015003957A2 (pt) alfa-1-microglobulina para uso no tratamento de doenças relacionadas com a mitocôndria
ECSP14027694A (es) Composiciones y métodos de polipéptidos-complejo de quelato de oligonucleótido

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)